Donald and Barbara Zucker School of Medicine at Hofstra/Northwell — New York, New York

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell has participated in 2 clinical trials.

Therapeutic areas: Focal Epilepsy, Pituitary Adenoma.

Sponsors: Engrail Therapeutics INC, University of Zurich.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Donald and Barbara Zucker School of Medicine at Hofstra/Northwell?

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Donald and Barbara Zucker School of Medicine at Hofstra/Northwell conducted?

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell has 2 clinical trials on record. Their work covers Focal Epilepsy, Pituitary Adenoma.

Is Donald and Barbara Zucker School of Medicine at Hofstra/Northwell accredited by Crixeo Health?

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Donald and Barbara Zucker School of Medicine at Hofstra/Northwell?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.